Hypertrophic Scarring: Current Knowledge of Predisposing Factors, Cellular and Molecular Mechanisms
Authors:
- 30 January 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 41 (1) , 48-56
Abstract
Hypertrophic scarring (HSc) is an age-old problem that still affects millions of people physically, psychologically, and economically. Despite advances in surgical techniques and wound care, prevention and treatment of HSc remains a challenge. Elucidation of factors involved in the development of this common fibroproliferative disorder is crucial for further progress in preventive and/or therapeutic measures. Our knowledge about pathophysiology of HSc at the cellular and molecular level has grown considerably in recent decades. In this article, current knowledge of predisposing factors and the cellular and molecular mechanisms of HSc has been reviewed.Keywords
Funding Information
- Canadian Institutes of Health Research
- WorkSafeBC
This publication has 80 references indexed in Scilit:
- Critical Role of Transforming Growth Factor Beta in Different Phases of Wound HealingAdvances in Wound Care, 2013
- Predicting severity of pathological scarring due to burn injuries: a clinical decision making tool using Bayesian networksInternational Wound Journal, 2012
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisProceedings of the National Academy of Sciences, 2012
- Spatial and Temporal Localization of the Melanocortin 1 Receptor and Its Ligand α–Melanocyte-Stimulating Hormone during Cutaneous Wound RepairJournal of Histochemistry & Cytochemistry, 2011
- The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healingNature Cell Biology, 2010
- The effect of versican G3 domain on local breast cancer invasiveness and bony metastasisBreast Cancer Research, 2007
- Formation and Function of the Myofibroblast during Tissue RepairJournal of Investigative Dermatology, 2007
- Proopiomelanocortin (POMC), the ACTH/ melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesisThe FASEB Journal, 2007
- Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injuryBurns, 2006
- Prevalence of hypertrophic scar formation and its characteristics among the Chinese populationBurns, 2005